These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 15070730)

  • 21. Promoter specificity and stability control of the p53-related protein p73.
    Lee CW; La Thangue NB
    Oncogene; 1999 Jul; 18(29):4171-81. PubMed ID: 10435630
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The N-terminal domain of p73 interacts with the CH1 domain of p300/CREB binding protein and mediates transcriptional activation and apoptosis.
    Zeng X; Li X; Miller A; Yuan Z; Yuan W; Kwok RP; Goodman R; Lu H
    Mol Cell Biol; 2000 Feb; 20(4):1299-310. PubMed ID: 10648616
    [TBL] [Abstract][Full Text] [Related]  

  • 23. WW domain containing oxidoreductase induces apoptosis in gallbladder-derived malignant cell by upregulating expression of P73 and PUMA.
    Wei D; Zhang X; Zou H; Wang L; Fu B; Wu X; Luo Z; Li X; Ge J; Li Y; Zhu H; Wang K; Wang T; Yang P; Hou Z; Wang W
    Tumour Biol; 2014 Feb; 35(2):1539-50. PubMed ID: 24127039
    [TBL] [Abstract][Full Text] [Related]  

  • 24. c-Abl stabilizes p73 by a phosphorylation-augmented interaction.
    Tsai KK; Yuan ZM
    Cancer Res; 2003 Jun; 63(12):3418-24. PubMed ID: 12810679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification and characterization of HIPK2 interacting with p73 and modulating functions of the p53 family in vivo.
    Kim EJ; Park JS; Um SJ
    J Biol Chem; 2002 Aug; 277(35):32020-8. PubMed ID: 11925430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regulation of p73 by Hck through kinase-dependent and independent mechanisms.
    Paliwal P; Radha V; Swarup G
    BMC Mol Biol; 2007 May; 8():45. PubMed ID: 17535448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relief of p53-mediated telomerase suppression by p73.
    Toh WH; Kyo S; Sabapathy K
    J Biol Chem; 2005 Apr; 280(17):17329-38. PubMed ID: 15734740
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Transactivation-deficient Delta TA-p73 inhibits p53 by direct competition for DNA binding: implications for tumorigenesis.
    Stiewe T; Theseling CC; Pützer BM
    J Biol Chem; 2002 Apr; 277(16):14177-85. PubMed ID: 11844800
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Distinct regulation of p53 and p73 activity by adenovirus E1A, E1B, and E4orf6 proteins.
    Steegenga WT; Shvarts A; Riteco N; Bos JL; Jochemsen AG
    Mol Cell Biol; 1999 May; 19(5):3885-94. PubMed ID: 10207112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. p73 competes with p53 and attenuates its response in a human ovarian cancer cell line.
    Vikhanskaya F; D'Incalci M; Broggini M
    Nucleic Acids Res; 2000 Jan; 28(2):513-9. PubMed ID: 10606650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MDM2 and MDMX bind and stabilize the p53-related protein p73.
    Ongkeko WM; Wang XQ; Siu WY; Lau AW; Yamashita K; Harris AL; Cox LS; Poon RY
    Curr Biol; 1999 Jul 29-Aug 12; 9(15):829-32. PubMed ID: 10469568
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pirh2, a ubiquitin E3 ligase, inhibits p73 transcriptional activity by promoting its ubiquitination.
    Wu H; Zeinab RA; Flores ER; Leng RP
    Mol Cancer Res; 2011 Dec; 9(12):1780-90. PubMed ID: 21994467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A role of p73 in mitotic exit.
    Merlo P; Fulco M; Costanzo A; Mangiacasale R; Strano S; Blandino G; Taya Y; Lavia P; Levrero M
    J Biol Chem; 2005 Aug; 280(34):30354-60. PubMed ID: 15985436
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Regulation of telomerase activity by the p53 family member p73.
    Beitzinger M; Oswald C; Beinoraviciute-Kellner R; Stiewe T
    Oncogene; 2006 Feb; 25(6):813-26. PubMed ID: 16205639
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Phosphorylation of the WWOX Protein Regulates Its Interaction with p73.
    Lahav N; Rotem-Bamberger S; Fahoum J; Dodson EJ; Kraus Y; Mousa R; Metanis N; Friedler A; Schueler-Furman O
    Chembiochem; 2020 Jul; 21(13):1843-1851. PubMed ID: 32185845
    [TBL] [Abstract][Full Text] [Related]  

  • 36. p73 function is inhibited by tumor-derived p53 mutants in mammalian cells.
    Di Como CJ; Gaiddon C; Prives C
    Mol Cell Biol; 1999 Feb; 19(2):1438-49. PubMed ID: 9891077
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Physical and functional interaction between p53 mutants and different isoforms of p73.
    Strano S; Munarriz E; Rossi M; Cristofanelli B; Shaul Y; Castagnoli L; Levine AJ; Sacchi A; Cesareni G; Oren M; Blandino G
    J Biol Chem; 2000 Sep; 275(38):29503-12. PubMed ID: 10884390
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HDM2 antagonist Nutlin-3 disrupts p73-HDM2 binding and enhances p73 function.
    Lau LM; Nugent JK; Zhao X; Irwin MS
    Oncogene; 2008 Feb; 27(7):997-1003. PubMed ID: 17700533
    [TBL] [Abstract][Full Text] [Related]  

  • 39. p73 transcriptional activity increases upon cooperation between its spliced forms.
    Alarcon-Vargas D; Fuchs SY; Deb S; Ronai Z
    Oncogene; 2000 Feb; 19(6):831-5. PubMed ID: 10698502
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
    John K; Alla V; Meier C; Pützer BM
    Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.